Skip to content

Author

Chuan-Long Guo

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Immunotoxicological mechanism of a dual-targeted nanocomposite: Mitochondrial stress-driven cGAS-STING activation in lung cancer.

Lung cancer remains a leading cause of cancer mortality. We developed a dual-targeting nanocomposite FU@TPP/BSA@MnO/UA that induces mitochondrial dysfunction and activates the cGAS-STING pathway. The nanocomposite features a BSA-Mn2 + core, a FU@TPP shell for sequential, dual-stage targeting-first recognizing P-selecti...

Hao-Fan Wang, Cheng-Shuang Wang, Shi-Yu Ma et al. · 0 citations
Review Open access Oct 2026

Diosmetin as a Promising Anticancer Agent: Mechanisms, Structural Optimization, and Advanced Delivery Systems

Diosmetin (Dio) is a natural flavonoid with broad-spectrum anticancer activity against various malignancies through mechanisms involving cell cycle arrest, apoptosis induction, metastasis inhibition, and modulation of oncogenic signaling pathways such as STAT3/c-Myc and PI3K/AKT/mTOR; with the exception of CDK2, whic...

Lin Long, Yu-Ning Liu, Jian-Hua Zang et al. · 0 citations
Sep 2026

Baicalein-loaded rhamnolipid nanomicelles target mitochondrial dysfunction and activate the cGAS-STING pathway for triple-negative breast cancer therapy.

Triple-negative breast cancer (TNBC) remains an intractable malignancy due to the lack of specific therapeutic targets and high metastatic potential. Herein, we fabricated rhamnolipid (RL)-encapsulated baicalein (BAI) nanomicelles (RL/BAI) via a thin-film hydration method. Molecular dynamics (MD) simulations revealed t...

Nan Wang, Shi-Yu Ma, Fang-Yu Jiao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.